Trial Profile
Olaparib Dose Escalation in Combination With High Dose Radiotherapy to the Breast Andregional Lymph Nodes in Patients With Breast Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Olaparib (Primary)
- Indications Advanced breast cancer; Inflammatory breast cancer
- Focus Adverse reactions
- 03 Aug 2021 Status changed from active, no longer recruiting to completed.
- 26 Jun 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Sep 2019.
- 26 Jun 2019 Status changed from recruiting to active, no longer recruiting.